Search

Your search keyword '"Valentin Calugaru"' showing total 152 results

Search Constraints

Start Over You searched for: Author "Valentin Calugaru" Remove constraint Author: "Valentin Calugaru"
152 results on '"Valentin Calugaru"'

Search Results

1. Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma

2. A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group

3. Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients

4. Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma

5. Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review

6. Adenoid Cystic Carcinoma of the Lacrimal Gland: High Dose Adjuvant Proton Therapy to Improve Patients Outcomes

7. Surgery and protontherapy in Grade I and II skull base chondrosarcoma: A comparative retrospective study.

8. Protontherapy to maintain local control of head and neck paragangliomas

9. The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers

10. Proton therapy for adult craniopharyngioma: Experience of a single institution in 91 consecutive patients

11. Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity

13. Data from Phase I Trial of Debio 1143, an Antagonist of Inhibitor of Apoptosis Proteins, Combined with Cisplatin Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

14. Supplementary Data from Phase I Trial of Debio 1143, an Antagonist of Inhibitor of Apoptosis Proteins, Combined with Cisplatin Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

15. Management Strategies in Clival and Craniovertebral Junction Chordomas: A 29-Year Experience

16. The Mutational Landscape of Skull-Base and Spinal Chordomas Identifies Potential Prognostic and Theranostic Biomarkers

17. Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial

18. Nouvelles indications de protonthérapie et essais cliniques en cours : tumeurs intracrâniennes

19. Role of proton therapy in reirradiation and in the treatment of sarcomas

20. [18F]-FDG PET and MRI radiomic signatures to predict the risk and the location of tumor recurrence after re-irradiation in head and neck cancer

21. Acute and late toxicities of patients infected with SARS-CoV-2 and treated for cancer with radiation therapy during the COVID-19 pandemic

22. Update of the EPTN atlas for CT- and MR-based contouring in Neuro-Oncology

23. Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensus

24. Addressing the dosimetric impact of bone cement and vertebroplasty in stereotactic body radiation therapy

25. Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx

26. High-dose proton therapy and tomotherapy for the treatment of sacral chordoma: a retrospective monocentric study

27. Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study

28. Proton therapy for head and neck squamous cell carcinomas: A review of the physical and clinical challenges

29. International assessment of interobserver reproducibility of flap delineation in head and neck carcinoma

30. Current practice in proton therapy delivery in adult cancer patients across Europe

31. A Comprehensive Analysis of the Relationship Between Dose Rate and Biological Effects in Preclinical and Clinical Studies, From Brachytherapy to Flattening Filter Free Radiation Therapy and FLASH Irradiation

32. CENP-A Subnuclear Localization Pattern as Marker Predicting Curability by Chemoradiation Therapy for Locally Advanced Head and Neck Cancer Patients

33. Post-lockdown management of oncological priorities and postponed radiation therapy following the COVID-19 pandemic: Experience of the Institut Curie

34. État des lieux de la protonthérapie en France en 2019

35. Clinical and technical challenges of cancer reirradiation: Words of wisdom

36. Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown Primary

37. Proposition de délinéation des volumes cibles anatomocliniques postopératoires de la tumeur primitive des cancers de l’ethmoïde

38. OC-0077 High-dose post-operative Protontherapy to improve the outcome of high-grade meningiomas

39. PO-0992 Outcomes and toxicities of curative reirradiation for head and neck carcinomas

40. Head and neck proton therapy in France: A missed opportunity or a challenge in front of us?

41. PH-0328 Current practice for selection of adult patients for proton therapy across Europe

42. Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal Cancers

43. Review of clinical applications of radiation-enhancing nanoparticles

44. A prospective multicentre REFCOR study of 470 cases of head and neck Adenoid cystic carcinoma: epidemiology and prognostic factors

45. Phase I Trial of Debio 1143, an Antagonist of Inhibitor of Apoptosis Proteins, Combined with Cisplatin Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

46. Update of the EPTN atlas for CT- and MR-based contouring in Neuro-Oncology

47. The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology

48. Protontherapy of head and neck paragangliomas: A monocentric study

49. Proton Therapy for Adult Craniopharyngioma

50. Phase I Study of Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients

Catalog

Books, media, physical & digital resources